Detalles de la búsqueda
1.
Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection.
J Hepatol
; 64(2): 292-300, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26453968
2.
Single- and multiple-ascending dose studies to evaluate the safety, tolerability, and pharmacokinetics of daclatasvir and asunaprevir in healthy male Japanese subjects.
Int J Clin Pharmacol Ther
; 53(4): 292-302, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25740262
3.
Calculation and mitigation of isotopic interferences in liquid chromatography-mass spectrometry/mass spectrometry assays and its application in supporting microdose absolute bioavailability studies.
Anal Chem
; 84(11): 4844-50, 2012 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-22540405
4.
Practical and efficient strategy for evaluating oral absolute bioavailability with an intravenous microdose of a stable isotopically-labeled drug using a selected reaction monitoring mass spectrometry assay.
Anal Chem
; 84(22): 10031-7, 2012 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23106420
5.
Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation.
Liver Transpl
; 18(9): 1053-9, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22706796
6.
Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in humans: in vitro and in vivo correlations.
Hepatology
; 54(6): 1924-35, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21809362
7.
Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1.
Hepatology
; 54(6): 1956-65, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21837752
8.
Quantification of 4-beta-hydroxycholesterol in human plasma using automated sample preparation and LC-ESI-MS/MS analysis.
Chem Res Toxicol
; 24(9): 1575-85, 2011 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-21728364
9.
Lack of an effect of human immunodeficiency virus coinfection on the pharmacokinetics of entecavir in hepatitis B virus-infected patients.
Antimicrob Agents Chemother
; 52(8): 2836-41, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18391039
10.
Population Pharmacokinetic Analysis of Asunaprevir in Subjects with Hepatitis C Virus Infection.
Infect Dis Ther
; 7(2): 261-275, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29589331
11.
Absence of a pharmacokinetic interaction between entecavir and adefovir.
J Clin Pharmacol
; 47(10): 1327-34, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17675455
12.
Population Pharmacokinetic Analysis of Daclatasvir in Subjects with Chronic Hepatitis C Virus Infection.
Clin Pharmacokinet
; 56(10): 1173-1183, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28066880
13.
Entecavir pharmacokinetics, safety, and tolerability after multiple ascending doses in healthy subjects.
J Clin Pharmacol
; 46(11): 1250-8, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17050790
14.
A Review of Daclatasvir Drug-Drug Interactions.
Adv Ther
; 33(11): 1867-1884, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27664109
15.
Using Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects to Simplify Dosing Recommendations.
Clin Pharmacokinet
; 55(12): 1559-1572, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27319000
16.
An open-label investigation into drug-drug interactions between multiple doses of daclatasvir and single-dose cyclosporine or tacrolimus in healthy subjects.
Clin Drug Investig
; 35(5): 281-9, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25896946
17.
Single-dose pharmacokinetics and safety of daclatasvir in subjects with renal function impairment.
Antivir Ther
; 20(5): 535-43, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25654812
18.
Effect of the coadministration of daclatasvir on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate.
Antivir Ther
; 19(5): 511-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24343001
19.
Evaluation of drug-drug interaction between daclatasvir and methadone or buprenorphine/naloxone.
J Int AIDS Soc
; 17(4 Suppl 3): 19628, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25394132
20.
The pharmacokinetics of daclatasvir and asunaprevir administered in combination in studies in healthy subjects and patients infected with hepatitis C virus.
Clin Drug Investig
; 34(9): 661-71, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25117173